StonvexLoading…
StonvexStonvexStonvexCore line items from GBCI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $26.63M | $101.07M | $72.54M | $46.91M |
Operating Income | $100.17M | $290.25M | $213.96M | $128.66M |
Net Income | $82.14M | $239.03M | $175.25M | $107.35M |
EPS (Diluted) | $0.63 | $1.99 | $1.51 | $0.93 |
Total Assets | $31.73B | $31.98B | $29.02B | $29.00B |
Total Liabilities | $27.49B | $27.76B | $25.41B | $25.47B |
Cash & Equivalents | $1.39B | $1.24B | $854.24M | $915.51M |
Free Cash Flow OCF − CapEx | $74.35M | $347.55M | $231.08M | $126.30M |
Shares Outstanding | 130.12M | 129.97M | 118.55M | 118.55M |